Tissue Repair Ltd (ASX:TRP)

Australia flag Australia · Delayed Price · Currency is AUD
0.155
+0.025 (19.23%)
Apr 29, 2026, 3:59 PM AEST
-28.74%
Market Cap 9.37M
Revenue (ttm) 3.38M
Net Income (ttm) -3.85M
Shares Out 60.46M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 125,168
Average Volume 39,534
Open 0.145
Previous Close 0.130
Day's Range 0.145 - 0.155
52-Week Range 0.130 - 0.480
Beta 0.32
RSI 46.41
Earnings Date May 28, 2026

About Tissue Repair

Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. The company utilizes Glucoprime technology, an immunogenic active pharmaceutical ingredient that activates macrophages and stimulates immune response for wound healing and skin regeneration. It develops TR-987, a topical drug in Phase III clinical trial for the treatment of chronic wounds and venous leg ulcers; and TR Pro+, a post-procedure gel for the aftercare of acut... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol TRP
Full Company Profile

Financial Performance

In fiscal year 2025, Tissue Repair's revenue was 2.63 million, an increase of 47.04% compared to the previous year's 1.79 million. Losses were -4.24 million, 2.43% more than in 2024.

Financial Statements

News

There is no news available yet.